
Annual report 2022
added 12-27-2025
AnPac Bio-Medical Science Co., Ltd. EPS Ratio 2011-2025 | ANPC
EPS is a measure used to assess the financial stability and profitability of a company. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the industry.
The term earnings per share (EPS) represents the portion of a company's earnings, net of taxes and preferred stock dividends, that is allocated to each share of common stock. The figure can be calculated simply by dividing net income earned in a given reporting period (usually quarterly or annually) by the total number of shares outstanding during the same term. Because the number of shares outstanding can fluctuate, a weighted average is typically used.
Calculated as:
EPS = (Net Income - Dividends on Preffered Stock) / Average Outstanding shares[1]
EPS can be calculated as a simple ratio of net income to shares, or in various variations, such as diluted EPS, which takes into account the potential issuance of new shares or convertible securities.
A high EPS ratio usually indicates that the company has good profitability and efficiency in utilizing its assets. However, other factors such as sales growth, debt burden, and the company's competitive position should also be considered.
EPS ratio is an important indicator for investors when making decisions to buy or sell a company's stock. It is also used by analysts to assess the financial condition of the company and its potential for growth and development.
Annual EPS Ratio AnPac Bio-Medical Science Co., Ltd.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.66 | -8.72 | -7.19 | -11.3 | -4.93 | - | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -2.66 | -11.3 | -6.96 |
References
- Khan, T. R., Islam, M. R., Choudhury, T. T., & Adnan, A. M. (2014). How earning per share (EPS) affects on share price and firm value.
EPS Ratio of other stocks in the Biotechnology industry
| Issuer | EPS Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-15.4 | - | 2.43 % | $ 254 M | ||
|
Pharming Group N.V.
PHAR
|
0.051 | $ 17.91 | -1.0 % | $ 7.59 B | ||
|
InflaRx N.V.
IFRX
|
-1.26 | $ 1.09 | -4.82 % | $ 152 M | ||
|
Alpine Immune Sciences
ALPN
|
-1.73 | - | - | $ 2.17 B | ||
|
Midatech Pharma plc
MTP
|
-31 | - | -18.52 % | $ 27.3 M | ||
|
Biophytis SA
BPTS
|
-0.26 | - | -13.47 % | $ 169 M | ||
|
Aptorum Group Limited
APM
|
-0.78 | $ 1.15 | -1.71 % | $ 6.27 M | ||
|
Arbutus Biopharma Corporation
ABUS
|
-0.44 | $ 4.78 | -0.31 % | $ 793 M | ||
|
Aclaris Therapeutics
ACRS
|
-1.71 | $ 3.03 | -0.49 % | $ 234 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-24.9 | - | - | $ 1.01 B | ||
|
AIkido Pharma
AIKI
|
-2.38 | - | 1.93 % | $ 17.4 M | ||
|
AlloVir
ALVR
|
-11.7 | - | 4.14 % | $ 49.1 M | ||
|
Ascendis Pharma A/S
ASND
|
-8.28 | $ 209.39 | -1.61 % | $ 5 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-10.7 | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
-3.25 | - | - | $ 10.1 M | ||
|
Aptevo Therapeutics
APVO
|
-87.4 | $ 0.6 | -35.8 % | $ 166 K | ||
|
Avenue Therapeutics
ATXI
|
-15.8 | - | -52.27 % | $ 4.45 M | ||
|
Autolus Therapeutics plc
AUTL
|
-0.86 | $ 1.66 | -1.49 % | $ 424 M | ||
|
AVROBIO
AVRO
|
0.27 | - | 1083.1 % | $ 745 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-0.53 | $ 3.12 | 0.81 % | $ 7.51 B | ||
|
BioDelivery Sciences International
BDSI
|
0.85 | - | -4.8 % | $ 255 M | ||
|
Athersys
ATHX
|
-0.39 | - | 3.77 % | $ 22.4 M | ||
|
BioVie
BIVI
|
-12.1 | $ 1.2 | -5.51 % | $ 1.77 M | ||
|
ARCA biopharma
ABIO
|
-3.87 | - | 1052.0 % | $ 415 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
-0.81 | - | -9.72 % | $ 5.89 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.01 | $ 0.22 | 24.46 % | $ 479 M | ||
|
Acasti Pharma
ACST
|
-0.79 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
-0.09 | - | -15.15 % | $ 60.3 M | ||
|
Berkeley Lights
BLI
|
-1.42 | - | -7.31 % | $ 87 M | ||
|
Albireo Pharma
ALBO
|
-1.77 | - | -0.23 % | $ 916 M | ||
|
BioNTech SE
BNTX
|
42.2 | $ 94.72 | -0.33 % | $ 27.2 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
3.29 | $ 27.09 | 1.04 % | $ 1.31 B | ||
|
BeiGene, Ltd.
BGNE
|
-0.47 | - | 0.49 % | $ 251 B | ||
|
Anika Therapeutics
ANIK
|
-5.64 | $ 9.6 | 1.27 % | $ 141 M | ||
|
bluebird bio
BLUE
|
-1.93 | - | - | $ 546 M | ||
|
Zai Lab Limited
ZLAB
|
-0.26 | $ 18.4 | -0.97 % | $ 18.2 B | ||
|
Catalyst Biosciences
CBIO
|
-1.41 | $ 12.33 | -0.29 % | $ 812 M | ||
|
Arena Pharmaceuticals
ARNA
|
-10.1 | - | -6.81 % | $ 3.04 B | ||
|
Acer Therapeutics
ACER
|
-1.66 | - | 2.71 % | $ 14 M | ||
|
Axon Enterprise
AXON
|
4.98 | $ 584.81 | -1.07 % | $ 44.3 B | ||
|
Ayala Pharmaceuticals
AYLA
|
-2.46 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
-2.16 | $ 2.44 | -3.56 % | $ 15.3 M | ||
|
AstraZeneca PLC
AZN
|
0.08 | $ 92.79 | 0.37 % | $ 96.9 B | ||
|
ChromaDex Corporation
CDXC
|
0.11 | - | -0.88 % | $ 598 M | ||
|
Certara
CERT
|
-0.08 | $ 8.9 | -0.17 % | $ 1.43 B | ||
|
Acorda Therapeutics
ACOR
|
-204 | - | -24.86 % | $ 820 K |